Meeting News Coverage

PARP inhibitor shows promise in treatment of breast, ovarian cancers

November 11, 2013
The novel PARP inhibitor BMN 673 improved response in patients with BRCA-related breast and ovarian cancers, according to study results presented at…
Meeting News Coverage

P-S6 potential ‘functional’ biomarker in BRAF-mutant melanoma

November 11, 2013
Suppression of the phosphorylation of the protein S6 after the initiation of RAF inhibitor therapy may serve as a functional biomarker to guide the…
Meeting News Coverage

Antibody-drug conjugate demonstrated activity against guanylyl cyclase C in pancreatic cancer

November 6, 2013
The antibody-drug conjugate MLN0264 demonstrated antitumor activity in pancreatic cancer xenograft models, according to study results presented at…
Meeting News CoveragePerspective

New technology accurately detected BRAF mutations in tissue samples

November 6, 2013
A new molecular diagnostic prototype platform detected BRAF mutations in cancer tissue samples faster and more accurately vs. Clinical Laboratory…
Meeting News Coverage

Dinaciclib potential inhibitor of tumor growth in pancreatic cancer

October 29, 2013
The novel agent dinaciclib demonstrated activity in xenographic models against the RAS pathway of the KRAS mutation associated with pancreatic…
Meeting News Coverage

CRLX101 plus bevacizumab demonstrated activity against HIF-1 alpha

October 28, 2013
CRLX101 combined with antiangiogenic therapy inhibited the upregulation of hypoxia-inducible factor 1 alpha, according to findings presented at the…